(ALAB) Astera Labs, Common Stock - Ratings and Ratios
Connectivity Platform, Retimers, Controllers, Switches
ALAB EPS (Earnings per Share)
ALAB Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 97.8% |
| Value at Risk 5%th | 133% |
| Reward | |
|---|---|
| Sharpe Ratio | 1.09 |
| Alpha | 43.23 |
| Character | |
|---|---|
| Hurst Exponent | 0.627 |
| Beta | 2.364 |
| Drawdowns 3y | |
|---|---|
| Max DD | 63.69% |
| Mean DD | 27.66% |
Description: ALAB Astera Labs, Common Stock September 29, 2025
Astera Labs, Inc. (NASDAQ: ALAB) is a California-based fabless semiconductor firm that builds and sells connectivity solutions aimed at cloud-scale and AI data-center infrastructure. Founded in 2017, the company targets hyperscalers and system OEMs with a portfolio that combines hardware and software to manage high-speed interconnects.
The core offering is an “intelligent connectivity platform” that fuses mixed-signal ASICs-featuring embedded microcontrollers, sensors, and retimers-with the COSMOS software suite. COSMOS provides link-level diagnostics, fleet-wide resource orchestration, and reliability-aware (RAS) management, enabling operators to monitor and optimize thousands of ports in real time.
Product lines include PCIe 5.0/CXL smart DSP retimers, Ethernet smart cable modules, CXL memory-connectivity controllers, and programmable fabric switches. These components are positioned to address the rapid migration to PCIe 5.0 and CXL standards, which analysts estimate will drive $12-$15 billion of incremental spend in the data-center interconnect market through 2028.
Recent financial disclosures show a year-over-year revenue growth of ~68 % in Q2 2024, with gross margins expanding to 55 % as the firm scales volume and shifts to higher-margin software licensing. The broader semiconductor connectivity segment is benefiting from a 10-12 % CAGR in AI-driven workloads, while supply-chain tightening on advanced silicon continues to create entry barriers for new competitors.
If you want a data-driven, quantitative assessment of ALAB’s valuation relative to its peers, a deeper dive on ValueRay’s platform can provide the metrics and scenario analysis you need.
ALAB Stock Overview
| Market Cap in USD | 27,952m |
| Sub-Industry | Semiconductors |
| IPO / Inception | 2024-03-20 |
| Return 12m vs S&P 500 | +63.49% |
| Analyst Rating | 4.47 of 5 |
ALAB Dividends
Currently no dividends paidALAB Growth Ratios
| CAGR | 158.89% |
| CAGR/Max DD Calmar Ratio | 2.49 |
| CAGR/Mean DD Pain Ratio | 5.75 |
| Current Volume | 4846.6k |
| Average Volume | 5850.4k |
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (198.9m TTM) > 0 and > 6% of Revenue (6% = 43.4m TTM) |
| FCFTA 0.16 (>2.0%) and ΔFCFTA 7.06pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 164.5% (prev 280.5%; Δ -116.0pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.19 (>3.0%) and CFO 263.7m > Net Income 198.9m (YES >=105%, WARN >=100%) |
| Net Debt (-140.4m) to EBITDA (123.1m) ratio: -1.14 <= 3.0 (WARN <= 3.5) |
| Current Ratio 12.78 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (180.6m) change vs 12m ago 15.18% (target <= -2.0% for YES) |
| Gross Margin 75.41% (prev 77.62%; Δ -2.21pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 60.65% (prev 31.10%; Δ 29.55pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -3.70 (EBITDA TTM 123.1m / Interest Expense TTM -31.9m) >= 6 (WARN >= 3) |
Altman Z'' 5.90
| (A) 0.85 = (Total Current Assets 1.29b - Total Current Liabilities 101.0m) / Total Assets 1.40b |
| (B) -0.02 = Retained Earnings (Balance) -34.6m / Total Assets 1.40b |
| (C) 0.10 = EBIT TTM 118.1m / Avg Total Assets 1.19b |
| (D) -0.24 = Book Value of Equity -30.5m / Total Liabilities 129.5m |
| Total Rating: 5.90 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 76.68
| 1. Piotroski 5.0pt = 0.0 |
| 2. FCF Yield 0.86% = 0.43 |
| 3. FCF Margin 31.73% = 7.50 |
| 4. Debt/Equity 0.00 = 2.50 |
| 5. Debt/Ebitda -1.14 = 2.50 |
| 6. ROIC - WACC (= 0.63)% = 0.79 |
| 7. RoE 18.02% = 1.50 |
| 8. Rev. Trend 95.44% = 7.16 |
| 9. EPS Trend 85.98% = 4.30 |
What is the price of ALAB shares?
Over the past week, the price has changed by -9.30%, over one month by -15.75%, over three months by -3.17% and over the past year by +88.34%.
Is Astera Labs, Common Stock a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ALAB is around 174.23 USD . This means that ALAB is currently overvalued and has a potential downside of 0.28%.
Is ALAB a buy, sell or hold?
- Strong Buy: 9
- Buy: 7
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the ALAB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 196 | 12.8% |
| Analysts Target Price | 196 | 12.8% |
| ValueRay Target Price | 205.1 | 18.1% |
ALAB Fundamental Data Overview November 11, 2025
P/E Trailing = 135.6475
P/E Forward = 107.5269
P/S = 38.6589
P/B = 30.6763
Beta = None
Revenue TTM = 723.0m USD
EBIT TTM = 118.1m USD
EBITDA TTM = 123.1m USD
Long Term Debt = 1.29m USD (from capitalLeaseObligations, last fiscal year)
Short Term Debt = 1.29m USD (from shortTermDebt, last fiscal year)
Debt = 1.29m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -140.4m USD (from netDebt column, last quarter)
Enterprise Value = 26.82b USD (27.95b + Debt 1.29m - CCE 1.13b)
Interest Coverage Ratio = -3.70 (Ebit TTM 118.1m / Interest Expense TTM -31.9m)
FCF Yield = 0.86% (FCF TTM 229.4m / Enterprise Value 26.82b)
FCF Margin = 31.73% (FCF TTM 229.4m / Revenue TTM 723.0m)
Net Margin = 27.50% (Net Income TTM 198.9m / Revenue TTM 723.0m)
Gross Margin = 75.41% ((Revenue TTM 723.0m - Cost of Revenue TTM 177.8m) / Revenue TTM)
Gross Margin QoQ = 76.25% (prev 75.84%)
Tobins Q-Ratio = 19.14 (Enterprise Value 26.82b / Total Assets 1.40b)
Interest Expense / Debt = -2479 % (Interest Expense -31.9m / Debt 1.29m)
Taxrate = -36.27% (negative due to tax credits) (-24.3m / 66.9m)
NOPAT = 160.9m (EBIT 118.1m * (1 - -36.27%)) [negative tax rate / tax credits]
Current Ratio = 12.78 (Total Current Assets 1.29b / Total Current Liabilities 101.0m)
Debt / Equity = 0.00 (Debt 1.29m / totalStockholderEquity, last quarter 1.27b)
Debt / EBITDA = -1.14 (Net Debt -140.4m / EBITDA 123.1m)
Debt / FCF = -0.61 (Net Debt -140.4m / FCF TTM 229.4m)
Total Stockholder Equity = 1.10b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.19% (Net Income 198.9m / Total Assets 1.40b)
RoE = 18.02% (Net Income TTM 198.9m / Total Stockholder Equity 1.10b)
RoCE = 10.69% (EBIT 118.1m / Capital Employed (Equity 1.10b + L.T.Debt 1.29m))
RoIC = 15.36% (NOPAT 160.9m / Invested Capital 1.05b)
WACC = 14.73% (E(27.95b)/V(27.95b) * Re(14.73%) + (debt cost/tax rate unavailable))
Discount Rate = 14.73% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 8.83%
[DCF Debug] Terminal Value 57.77% ; FCFE base≈174.3m ; Y1≈175.2m ; Y5≈187.7m
Fair Price DCF = 8.50 (DCF Value 1.43b / Shares Outstanding 168.9m; 5y FCF grow 0.0% → 3.0% )
EPS Correlation: 85.98 | EPS CAGR: 123.4% | SUE: 1.68 | # QB: 2
Revenue Correlation: 95.44 | Revenue CAGR: 141.7% | SUE: 3.54 | # QB: 3
Additional Sources for ALAB Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle